Corvus Pharmaceuticals Inc (NASDAQ:CRVS) concluded the trading at $3.52 on Wednesday, April 23 with a rise of 5.71% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $3.33 and 5Y monthly beta
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) traded at $3.30 at last check on current trade day and made an upward move of 1.70% on its previous day’s price. Looking at the stock we see that its previous close was $3.24 and the beta (5Y monthly) reads 0.698
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) shares, rose in value on Friday, March 28, with the stock price up by 0.30% to the previous day’s close as strong demand from buyers drove the stock to $3.38. Actively observing the price movement in the last trading, the stock
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) traded at $4.62 at close of the session on Friday, March 07 and made an upward move of 5.48% on its previous day’s price. Corvus Pharmaceuticals Inc has a market cap of $296.87 million and is expected to release its quarterly
The trading price of Corvus Pharmaceuticals Inc (NASDAQ:CRVS) closed higher on Tuesday, March 04, and closing at $4.00, 1.27% higher than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $10.00 and a 52-week low
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
